Additional Proxy Soliciting Materials (definitive) (defa14a)
30 6월 2023 - 7:00PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section
14(a) of the Securities Exchange Act of 1934
|
☒ Filed by the Registrant
|
☐ Filed by a Party other than the Registrant
|
Check the appropriate box:
|
☐
|
Preliminary Proxy Statement
|
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
☐
|
Definitive Proxy Statement
|
| ☒ |
Definitive Additional Materials
|
|
☐
|
Soliciting Material under §240.14a-12
|
WINDTREE THERAPEUTICS, INC.
(Name of Registrant as Specified In Its
Charter)
(Name of Person(s) Filing Proxy Statement, if other than the
Registrant)
Payment of Filing Fee (Check all boxes that apply):
|
☐
|
Fee paid previously with preliminary materials
|
|
☐
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
|
Windtree Therapeutics (NASDAQ:WINT)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Windtree Therapeutics (NASDAQ:WINT)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
